Merck Q2 profit off on restructuring charge, but core earnings beat on higher revenue
05:26 EDT 27 Jul 2012 | Proactive Investors
Global health care giant Merck & Co (NYSE:MRK) said Friday second quarter net profit fell 11 per cent as a restructuring charge masked higher revenue, but adjusted earnings beat analyst estimates. The company saw increased sales for its diabetes..
Original Article: Merck Q2 profit off on restructuring charge, but core earnings beat on higher revenue
More From BioPortfolio on "Merck Q2 profit off on restructuring charge, but core earnings beat on higher revenue"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
